²é¿´: 31  |  »Ø¸´: 0

danyuneau

гæ (³õÈëÎÄ̳)

[ÈÎÎñ] ÂÛÎÄÑ¡¿¯×ż±±ÏÒµ£¡

ÏÖ½ð½±Àø 5 Ôª
Çë×ÐϸÔĶÁÖ÷ÌùÄÚÈÝ£¬¸ù¾ÝÒªÇóÍê³ÉÈÎÎñºó£¬Í¨¹ý»ØÌûµÄÐÎʽÀ´ÁìÈ¡Éͽð¡£

ÄÚÈÝ

±¾ÈËÒÑÍê³ÉÎÄÕµÄд×÷£¬µ«ÊÇÓÉÓÚ±ÏÒµÔÚ¼´£¬ÐèÒªÔÚÃ÷Äê3Ô·Ý֮ǰÄõ½accept£¬Ï£ÍûÓÐÈËÄܹ»¸ù¾ÝÏÂÊöÄÚÈݰïÃ¦ÍÆ¼ö½ÓÊÕ¼¸ÂʸߺÍÉó¸åÖÜÆÚ¶ÌµÄÎÄÕ£¬·Ç³£¸Ðл£¡
Vinpocetine has found wide application in the treatment of cerebral diseases, and it shows benefits especially in the treatment of stroke and epilepsy. However, it has the disadvantages of low bioavailability and cardiac toxicity. Studies have shown that vinpocetine derivatives with higher potency can be obtained through modification and screening. The aim of this study is to assess the pharmacodynamics of vinpocetine derivative VPK from such aspects as anti-cerebral ischemia, anti-epilepsy, inhibiting PDE1 and Na+ channel.
The changes in the volume of cerebral infarction were examined after pharmacotherapy by employing rat model of cerebral ischemia reperfusion injury. PTZ-kindled SD rat and cynomolgus macaque epilepsy models were used to detect the latency, counts and duration of epilepsy, and to study the pharmacodynamic actions of VPK in vivo; the inhibitory effects of VPK on PDE1 and Na+ channel were also detected and its pharmacodynamic actions in vitro on stroke and epilepsy were expounded at the molecular level.
With respect to its in vivo pharmacodynamic effects, VPK was significantly superior to vinpocetine and carbamazepine in inhibiting cerebral infarction caused by middle cerebral artery occlusion (MCAO), prolonging the latency of epilepsy, reducing the counts and duration of epilepsy, which showed dose-dependent effect. At the molecular level in vitro, the 50% inhibitory concentrations (IC50) of VPK and vinpocetine for PDE1 were 1.97 ¦ÌM and 17.4 ¦ÌM respectively, and IC50s for NaV1.1 were 0.013 ¦ÌM and 0.25 ¦ÌM respectively. The results above show that the pharmacodynamic effects of VPK are significantly superior to that of vinpocetine and carbamazepine.
VPK has higher potency than vinpocetine in the treatment of stroke and epilepsy, which suggests that it may become a new drug candidate which is more effective in the treatment of stroke and epilepsy.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ danyuneau µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 290Çóµ÷¼Á +6 ¿×Ö¾ºÆ 2026-03-12 11/550 2026-03-17 14:41 by ÖÜÖÛÖÛ77
[¿¼ÑÐ] ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС« +3 TqlXswl 2026-03-16 6/300 2026-03-17 13:44 by ѧº£Æ¯²´
[¿¼ÑÐ] ±¾ÈË¿¼085602 »¯Ñ§¹¤³Ì ר˶ +15 ²»ÖªµÀ½Ðʲô£¡ 2026-03-15 17/850 2026-03-17 10:13 by Sammy2
[¿¼ÑÐ] 304Çóµ÷¼Á +7 СÐÜjoy 2026-03-14 7/350 2026-03-17 08:53 by ÎíÉ¢ºóÏàÓölc
[¿¼ÑÐ] Ò»Ö¾Ô¸£¬¸£ÖÝ´óѧ²ÄÁÏר˶339·ÖÇóµ÷¼Á +3 ľ×ÓmomoÇàÕù 2026-03-15 3/150 2026-03-17 07:52 by laoshidan
[¿¼ÑÐ] 304Çóµ÷¼Á +4 ahbd 2026-03-14 4/200 2026-03-16 16:48 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 283Çóµ÷¼Á +10 С¥¡£ 2026-03-12 14/700 2026-03-16 16:08 by 13811244083
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Ò»Ö¾Ô¸Äϲý´óѧ327Çóµ÷¼ÁÍÆ¼ö +7 Ncdx123456 2026-03-13 8/400 2026-03-16 12:15 by karry wen
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] 070305Çóµ÷¼Á +3 mlpqaz03 2026-03-14 4/200 2026-03-15 11:04 by peike
[¿¼ÑÐ] 328Çóµ÷¼Á +3 5201314Lsy£¡ 2026-03-13 6/300 2026-03-14 15:31 by hyswxzs
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-03-13 4/200 2026-03-14 08:37 by zhukairuo
[¿¼ÑÐ] 0805£¬333Çóµ÷¼Á +3 112253525 2026-03-10 3/150 2026-03-13 23:42 by JourneyLucky
[¿¼ÑÐ] 279Çóµ÷¼Á +3 Dizzy123@ 2026-03-10 3/150 2026-03-13 23:02 by JourneyLucky
[¿¼ÑÐ] 310Çóµ÷¼Á +3 ¡¾ÉÏÉÏÇ©¡¿ 2026-03-11 3/150 2026-03-13 16:16 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á +3 ³ÌÓ꺼 2026-03-12 3/150 2026-03-13 15:06 by JourneyLucky
[¿¼ÑÐ] 333Çóµ÷¼Á +3 152697 2026-03-12 4/200 2026-03-13 07:08 by Iveryant
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-03-12 4/200 2026-03-12 19:33 by Çóµ÷¼Ázz
[¿¼ÑÐ] 279Çóµ÷¼Á +3 Īxiao 2026-03-10 4/200 2026-03-11 08:06 by Õ¶»êµÎÍÃ×Ó£¡
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û